Skip to main content
Novartis AG (NVSEF)
OTCMKTS · Delayed Price · Currency is USD
126.62
+0.31 (0.25%)
At close: Dec 4, 2025

Novartis AG Revenue

Novartis AG had revenue of $14.36B in the quarter ending September 30, 2025, with 9.00% growth. This brings the company's revenue in the last twelve months to $56.37B, up 12.88% year-over-year. In the year 2024, Novartis AG had annual revenue of $51.72B with 10.85% growth.

Revenue (ttm)
56.37B
Revenue Growth
+12.88%
P/S Ratio
4.53
Revenue / Employee
742.88K
Employees
75,883
Market Cap
255.15B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202451.72B5.06B10.85%
Dec 31, 202346.66B3.20B7.36%
Dec 31, 202243.46B-513.00M-1.17%
Dec 31, 202143.97B-5.92B-11.87%
Dec 31, 202049.90B1.22B2.51%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Veradigm 588.02M
Elite Pharmaceuticals 122.89M
Glass House Brands 196.17M
American Oncology Network 1.76B
Northwest Biotherapeutics 937.00K
Silence Therapeutics 25.83M
Global Cord Blood 196.10M
Zomedica 29.45M
Revenue Rankings

Novartis AG News

More News